EDITOR’S NOTE: Malaria No More’s new Chief Executive Officer, Dr. William (Bill) Steiger, added the following on the Fiscal Year (FY) 2026 National Security, Department of State, and Related Programs (NSRP) appropriations bill, which passed the U.S. House of Representatives on February 3, 2026:

Malaria No More applauds the final passage of the National Security, Department of State, and Related Programs (NSRP) appropriations bill for FY 2026, which sustains U.S. support for bilateral malaria assistance at $795 million. With bipartisan support for this life-saving work, Congress has made clear: America remains committed to the fight against malaria. 

We also welcome the legislation’s establishment of a $50 million Prevention, Treatment, and Response Initiative to invest in the development of innovative technologies to prevent and treat malaria and other infectious diseases.

We note further that, while Congress establishes in the NSRP bill a series of explicit, stringent, and much-needed accountability requirements regarding the transition of the President’s Emergency Plan for AIDS Relief (PEPFAR) to national financial ownership and management, such requirements do not extend to other flagship global health programs like the U.S. President’s Malaria Initiative (PMI). Malaria No More encourages Congress to hold the Administration, both in future legislation and through general oversight, to similarly high standards and rigorous timelines for consultation and reporting on PMI and other malaria activities.

Malaria No More stands ready to support the effective implementation of the America First Global Health Strategy, which the NSRP bill funds. We note this process will require annual assessments of country readiness; quantifiable performance metrics; benchmarks for transition, including for host-country co-investment commitments; provisions to preserve the integrity of programs; and contingency plans.

We also urge the Department of State to act swiftly to comply with the language in the NSRP bill’s Joint Explanatory Statement that directs the Administration to use previously appropriated funds to meet the United States’ pledge to the Seventh Replenishment of the Global Fund to Fight AIDS, Tuberculosis and Malaria.

---

January 13, 2026 (Washington, D.C.) — Malaria No More issued the following statement on the FY26 National Security, Department of State, and Related Programs (NSRP) appropriations bill, the text of which was released by the House Appropriations Committee earlier this week:  
 
Malaria No More is pleased to see strong bipartisan, bicameral support for maintaining $795 million in bilateral malaria assistance in the FY26 National Security, Department of State, and Related Programs appropriations bill.   

This is a pivotal moment in the fight against malaria and with transformative new technologies on the horizon — from next-generation treatments, vaccines, and vector control tools — the next few years represent a generational opportunity to turn the tide against this deadly disease. Malaria No More is grateful to Chairman Graham, Chairman Diaz-Balart, Ranking Member Schatz, and Ranking Member Frankel for recognizing the indispensable value of sustained U.S. funding for malaria.  

Meeting this moment will also require the support of multilateral partners, which is why we are pleased to see $300 million for Gavi, the Vaccine Alliance and $1.25 billion for the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) included in the legislation.  

The Joint Explanatory Statement which accompanies the bill underscores Congress’ support for the Global Fund, including fulfilling the Administration’s full $4.6 billion pledge. We also welcome language in the statement supportive of the America First Global Health Strategy (AFGHS) and malaria’s role in spurring innovation and expanding opportunities for American businesses.  

Malaria No More urges the House and Senate to quickly pass this bipartisan bill and looks forward to working with the Administration and Congress to ensure these funds are disbursed fully and in accordance with Congressional intent.  

###